Pointe Capital Management LLC

Position in AZN — Astrazeneca PLC

CIK 1640335 GROSSE POINTE FARMS, MI

Position in AZN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$411,475

-$133,641 QoQ

Shares Held

2,170

-21.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#916

of 1,459 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pointe Capital Management LLC holds $3,106,347 across 6 Drug Manufacturers - General names. AZN ranks #3 (13.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,183	$1,418,925
2	NVS	Novartis AG	2,977	$466,555
3	AZN	Astrazeneca PLC This page	2,170	$411,475
4	MRK	Merck & Co., Inc.	2,386	$306,601
5	JNJ	Johnson & Johnson	1,024	$260,065
6	PFE	Pfizer Inc	10,080	$242,726

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$411,475	2,170	-21.5%	Shares	Sole	2026-08-14
2026-03-31	$545,116	2,764	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.